bemegride has been researched along with Disease Models, Animal in 7 studies
Bemegride: A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Activated lipid peroxidation observed in brain homogenates in experimental choreoid hyperkinesis and bemegride epilepsy can be arrested by antioxidant pretreatment." | 3.69 | [The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy]. ( Aliev, AN; Aliev, MN; Mamedbeĭli, TN; Rzaev, RN, 1994) |
| "Bemegride activation was performed in order to evaluate the predisposition of epileptogenicity of FSECs." | 1.40 | Electroencephalographic features of familial spontaneous epileptic cats. ( Fujita, M; Hamamoto, Y; Hasegawa, D; Kuwabara, T; Matsuki, N; Mizoguchi, S; Ogawa, F; Uchida, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, D | 1 |
| Mizoguchi, S | 1 |
| Kuwabara, T | 1 |
| Hamamoto, Y | 1 |
| Ogawa, F | 1 |
| Matsuki, N | 1 |
| Uchida, K | 1 |
| Fujita, M | 1 |
| Aliev, MN | 1 |
| Rzaev, RN | 1 |
| Mamedbeĭli, TN | 1 |
| Aliev, AN | 1 |
| Eigyo, M | 1 |
| Shiomi, T | 1 |
| Inoue, Y | 1 |
| Sakaguchi, I | 1 |
| Ishibashi, C | 1 |
| Murata, S | 1 |
| Koyabu, K | 1 |
| Matsushita, A | 1 |
| Adachi, I | 1 |
| Ueda, M | 1 |
| Nakano, H | 1 |
| Saito, K | 1 |
| Suzuki, K | 1 |
| Cherchenko, AP | 1 |
| Todor, IM | 1 |
| van Duijn, H | 1 |
| Meyer, JS | 1 |
| Kanda, T | 1 |
| Shinohara, Y | 1 |
| Fukuuchi, Y | 1 |
7 other studies available for bemegride and Disease Models, Animal
| Article | Year |
|---|---|
Electroencephalographic features of familial spontaneous epileptic cats.
Topics: Animals; Bemegride; Brain; Cats; Convulsants; Disease Models, Animal; Electrodes, Implanted; Electro | 2014 |
[The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy].
Topics: Animals; Antioxidants; Bemegride; Brain Chemistry; Chorea; Disease Models, Animal; Drug Evaluation, | 1994 |
Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice.
Topics: Administration, Oral; Animals; Anticonvulsants; Bemegride; Calcium Channel Blockers; Dihydropyridine | 1994 |
Clinico-ECoG correlate of megimide-induced epileptic seizures in epilepsy-prone El and its mother strain nonepileptic ddY mice.
Topics: Animals; Bemegride; Disease Models, Animal; Electroencephalography; Electromyography; Epilepsy; Fema | 1996 |
[Changes in energy metabolism in the brain of bemegride-kindled rabbits].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Bemegride; Cerebral Cortex; Convulsants; D | 2002 |
Superiority of clonazepam over diazepam in experimental epilepsy.
Topics: Animals; Anticonvulsants; Bemegride; Benzazepines; Cats; Cobalt; Diazepam; Disease Models, Animal; E | 1973 |
Changes in cerebrospinal fluid sodium and potassium concentrations during seizure activity.
Topics: Animals; Bemegride; Cerebral Arteries; Disease Models, Animal; Haplorhini; Potassium; Seizures; Sodi | 1970 |